As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the April 2020 Medicare Part D formulary updates included 65 new drugs, 34 of which are new generic drugs - with a total of 60 new generic equivalents (variations of manufacturer, drug-strength, and packaging).
Below is a full list of the new generics added to
the 2020 Medicare Part D (PDP) and Medicare Advantage plan (MAPD) formularies:
|
|
Number of |
Number of |
| ADAPALENE 0.1% SOLUTION [Plixda] | 2 | 32 |
| ALENDRONATE SODIUM 10 MG TABLET [Fosamax] | 65 | 388 |
| AMLODIPINE-VALSARTAN 10-160 MG TABLET [Exforge] | 60 | 362 |
| AMLODIPINE-VALSARTAN 10-320 MG TABLET [Exforge] | 60 | 364 |
| AMLODIPINE-VALSARTAN 5-160 MG TABLET [Exforge] | 60 | 364 |
| AMLODIPINE-VALSARTAN 5-320 MG TABLET [Exforge] | 60 | 362 |
| AMPHETAMINE ER 1.25 MG/ML SUSP BP 24H [Adzenys] | 0 | 10 |
| BUDESONIDE-FORMOTEROL 160-4.5 HFA AER AD [Symbicort] | 2 | 31 |
| BUDESONIDE-FORMOTEROL 80-4.5 HFA AER AD [Symbicort] | 2 | 31 |
| CALCIPOTRIENE-BETAMETH DP SUSPENSION [Taclonex Scalp] | 5 | 76 |
| DAPSONE 7.5% GEL W/PUMP [Aczone] | 2 | 35 |
| DEXTROAMPHETAMINE 5 MG/5 ML SOLUTION [ProCentra] | 7 | 114 |
| DIAZEPAM 10 MG RECTAL GEL SYST KIT [Diastat] | 64 | 381 |
| DIAZEPAM 2.5 MG RECTAL GEL SYST KIT [Diastat] | 65 | 382 |
| DIAZEPAM 20 MG RECTAL GEL SYST KIT [Diastat] | 64 | 381 |
| DOXEPIN HCL 3 MG TABLET [Silenor] | 31 | 184 |
| DOXEPIN HCL 6 MG TABLET [Silenor] | 31 | 184 |
| ELURYNG VAGINAL RING [NuvaRing] | 27 | 284 |
| ETONOGESTREL-EE VAGINAL RING [NuvaRing] | 27 | 287 |
| EUTHYROX 100 MCG TABLET | 49 | 267 |
| EUTHYROX 112 MCG TABLET | 49 | 267 |
| EUTHYROX 125 MCG TABLET | 49 | 267 |
| EUTHYROX 137 MCG TABLET | 49 | 267 |
| EUTHYROX 150 MCG TABLET | 49 | 267 |
| EUTHYROX 175 MCG TABLET | 49 | 267 |
| EUTHYROX 200 MCG TABLET | 49 | 267 |
| EUTHYROX 25 MCG TABLET | 49 | 267 |
| EUTHYROX 50 MCG TABLET | 49 | 267 |
| EUTHYROX 75 MCG TABLET | 49 | 267 |
| EUTHYROX 88 MCG TABLET | 49 | 267 |
| EVEROLIMUS 2.5 MG TABLET [Afinitor] | 60 | 337 |
| EVEROLIMUS 5 MG TABLET [Afinitor] | 60 | 337 |
| EVEROLIMUS 7.5 MG TABLET [Afinitor] | 60 | 337 |
| HYDROCODONE ER 10 MG CAPSULE 12H [Zohydro] | 9 | 65 |
| HYDROCODONE ER 15 MG CAPSULE 12H [Zohydro] | 9 | 65 |
| HYDROCODONE ER 20 MG CAPSULE 12H [Zohydro] | 9 | 67 |
| HYDROCODONE ER 30 MG CAPSULE 12H [Zohydro] | 9 | 65 |
| HYDROCODONE ER 40 MG CAPSULE 12H [Zohydro] | 9 | 65 |
| HYDROCODONE ER 50 MG CAPSULE 12H [Zohydro] | 9 | 65 |
| INSULIN ASPART 100 UNIT/ML CARTRIDGE | 0 | 64 |
| INSULIN ASPART 100 UNIT/ML INSULIN PEN [NovoLog PenFill] | 0 | 64 |
| INSULIN ASPART 100 UNIT/ML VIAL [NovoLog PenFill] | 0 | 62 |
| INSULIN ASPART PROT-INSULN ASP INSULIN PEN [NovoLog Mix 70/30] | 0 | 65 |
| INSULIN ASPART PROT-INSULN ASP VIAL [NovoLog Mix 70/30] | 0 | 65 |
| ISOSORBIDE DINITRATE 40 MG TABLET [Sorbitrate] | 18 | 125 |
| LEVOBUNOLOL 0.5% EYE DROPS [Betagan] | 58 | 378 |
| MESALAMINE ER 0.375 GRAM CAPSULE 24H [Apriso] | 40 | 266 |
| METHSCOPOLAMINE BROM 2.5 MG TABLET [Pamine] | 20 | 221 |
| METHSCOPOLAMINE BROM 5 MG TABLET [Pamine Forte] | 20 | 219 |
| METOPROLOL SUCC ER 100 MG TABLET ER 24H [Toprol XL] | 65 | 388 |
| NIKKI 3 MG-0.02 MG TABLET [Yaz] | 58 | 350 |
| PENICILLAMINE 250 MG TABLET [Depen] | 62 | 367 |
| PENTAMIDINE 300 MG INHAL POWDER VIAL-NEB [NebuPent] | 63 | 378 |
| PENTAMIDINE 300 MG VIAL [Pentam] | 65 | 375 |
| SODIUM CHLORIDE 3% IV SOLUTION | 45 | 310 |
| SUCRALFATE 1 GM/10 ML ORAL SUSPENSION [Carafate] | 22 | 225 |
| TRAMADOL HCL 100 MG TABLET | 14 | 108 |
| TRAVOPROST 0.004% EYE DROPS [Travatan] | 52 | 339 |
| TRIAMCINOLONE 0.05% OINTMENT [Trianex] | 12 | 111 |
| VERAPAMIL 120 MG TABLET [Calan] | 65 | 388 |
What Could the Addition of New Generic Drugs Mean to You?
- You may be able to save money by switching
from the brand-name drug to its generic equivalent – with your prescriber’s
approval and a new prescription. Please note, you will need to look
carefully at coverage costs as we have found that many 2020 generics are being
offered on the same tier as their brand-name equivalent or the generics do not
have a significantly lower retail price.
- Your brand-name drug may no longer be
available if a generic is now available. Based on past
experience, you may find that many Medicare Part D plans discontinue
coverage for the brand-name drug in the months following the
introduction of the generic equivalent - or your plan may immediately drop the brand-name drug now that the generic is being introduced
.
If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you must continue taking the brand-name drug, you will need to ask your plan for a formulary exception to continue coverage for your brand-name drug.
You can click for a chart showing the trends in formulary coverage for some of the more popular Medicare drugs and their generic equivalents.